DIY Life Web Search

  1. Ads

    related to: breast cancer treatment drugs

Search results

  1. Results From The WOW.Com Content Network
  2. FDA expands approval of breast cancer drug Kisqali to earlier ...

    www.aol.com/news/fda-expands-approval-breast...

    In a phase 3 clinical trial from the drugmaker Novartis, Kisqali reduced the risk of a patient’s breast cancer coming back by 25% after three years when given in addition to standard treatments ...

  3. Aromatase inhibitor - Wikipedia

    en.wikipedia.org/wiki/Aromatase_inhibitor

    Aromatase inhibitors (AIs) are a class of drugs used in the treatment of breast cancer in postmenopausal women and in men, [1][2] and gynecomastia in men. They may also be used off-label to reduce estrogen conversion when supplementing testosterone exogenously. They may also be used for chemoprevention in women at high risk for breast cancer.

  4. Breast cancer management - Wikipedia

    en.wikipedia.org/wiki/Breast_cancer_management

    Staging breast cancer is the initial step to help physicians determine the most appropriate course of treatment. As of 2016, guidelines incorporated biologic factors, such as tumor grade, cellular proliferation rate, estrogen and progesterone receptor expression, human epidermal growth factor 2 (HER2) expression, and gene expression profiling into the staging system.

  5. Breast cancer chemotherapy - Wikipedia

    en.wikipedia.org/wiki/Breast_cancer_chemotherapy

    Breast cancer chemotherapy. A woman being treated with docetaxel chemotherapy for breast cancer. Cold mittens and wine chilling devices are placed on her hands and feet to prevent deleterious effects on the nails. Similar strategies can be used to prevent hair loss. Breast cancer chemotherapy refers to the use of cytotoxic drugs (chemotherapy ...

  6. Palbociclib - Wikipedia

    en.wikipedia.org/wiki/Palbociclib

    Palbociclib. Palbociclib, sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of HR -positive and HER2 -negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. [5][6] Palbociclib was the first CDK4/6 inhibitor to be approved as a cancer therapy.

  7. Health Rounds: Breastfeeding is safe for breast cancer survivors

    www.aol.com/news/health-rounds-breastfeeding...

    Breastfeeding found to be safe after breast cancer treatment. ... Adding Merck's immunotherapy drug Keytruda to current standard treatments for gynecological cancers can provide meaningful ...

  1. Ads

    related to: breast cancer treatment drugs